Biblio

Export 1231 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is D  [Clear All Filters]
Journal Article
D. A. Jehu, Davis, J. C., Gill, J., Oke, O., and Liu-Ambrose, T., “The Effect of Exercise on Falls in People Living with Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 92, no. 4, pp. 1199-1217, 2023.
W. Scott Kim, Fu, Y. H., Dobson-Stone, C., Hsiao, J. - H. T., Shang, K., Hallupp, M., Schofield, P. R., Garner, B., Karl, T., and Kwok, J. B. J., “Effect of Fluvoxamine on Amyloid-β Peptide Generation and Memory.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1777-1787, 2018.
M. S. Weinberg, He, Y., Kivisäkk, P., Arnold, S. E., and Das, S., “Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S355-S365, 2024.
M. Ramos-Goicoa, Galdo-Álvarez, S., Díaz, F., and Zurrón, M., “Effect of Normal Aging and of Mild Cognitive Impairment on Event-Related Potentials to a Stroop Color-Word Task.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1487-501, 2016.
Y. Xu, Vasiljevic, E., Deming, Y. K., Jonaitis, E. M., Koscik, R. L., Van Hulle, C. A., Lu, Q., Carboni, M., Kollmorgen, G., Wild, N., Carlsson, C. M., Johnson, S. C., Zetterberg, H., Blennow, K., and Engelman, C. D., “Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.”, J Alzheimers Dis, vol. 94, no. 4, pp. 1587-1605, 2023.
A. Katrine Bergland, Dalen, I., Larsen, A. Inge, Aarsland, D., and Soennesyn, H., “Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.”, J Alzheimers Dis, vol. 56, no. 2, pp. 575-584, 2017.
H. Macpherson, Brownell, S., Harris, E., Duckham, R. L., O'Connell, S., Meyer, B. J., Mirzaee, S., and Daly, R. M., “Effects of a 6-Month Multifaceted Diet and Exercise Intervention on Cognition in Older Adults at Risk of Cognitive Decline: The PONDER Double-Blind, Placebo-Controlled Randomized Trial.”, J Alzheimers Dis, vol. 89, no. 1, pp. 247-263, 2022.
H. Macpherson, Brownell, S., Harris, E., Duckham, R. L., O'Connell, S., Meyer, B. J., Mirzaee, S., and Daly, R. M., “Effects of a 6-Month Multifaceted Diet and Exercise Intervention on Cognition in Older Adults at Risk of Cognitive Decline: The PONDER Double-Blind, Placebo-Controlled Randomized Trial.”, J Alzheimers Dis, vol. 89, no. 1, pp. 247-263, 2022.
C. Boutoleau-Bretonnière, Pouclet-Courtemanche, H., Gillet, A., Bernard, A., Deruet, A. Laure, Gouraud, I., Mazoue, A., Lamy, E., Rocher, L., Kapogiannis, D., and Haj, M. El, “The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis.”, J Alzheimers Dis, vol. 76, no. 1, pp. 41-47, 2020.
N. Soldevila-Domenech, Forcano, L., Boronat, A., Lorenzo, T., Piera, I., Puig-Pijoan, A., Mateus, J., Gómez, J. María Gon, Knezevic, I., Soteras, A., Fauria, K., Pizarro, N., Molinuevo, J. Luis, and de la Torre, R., “Effects of COVID-19 Home Confinement on Mental Health in Individuals with Increased Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1015-1021, 2021.
J. van Santen, Dröes, R. - M., Holstege, M., Henkemans, O. Blanson, van Rijn, A., de Vries, R., van Straten, A., and Meiland, F., “Effects of Exergaming in People with Dementia: Results of a Systematic Literature Review.”, J Alzheimers Dis, vol. 63, no. 2, pp. 741-760, 2018.
J. van Santen, Dröes, R. - M., Holstege, M., Henkemans, O. Blanson, van Rijn, A., de Vries, R., van Straten, A., and Meiland, F., “Effects of Exergaming in People with Dementia: Results of a Systematic Literature Review.”, J Alzheimers Dis, vol. 63, no. 2, pp. 741-760, 2018.
M. - T. Pertl, Benke, T., Zamarian, L., and Delazer, M., “Effects of Healthy Aging and Mild Cognitive Impairment on a Real-Life Decision-Making Task.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1077-1087, 2017.
H. Kaur, Golovko, S., Golovko, M. Y., Singh, S., Darland, D. C., and Combs, C. K., “Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 3, pp. 1083-1102, 2020.
S. Craft, Claxton, A., Baker, L. D., Hanson, A. J., Cholerton, B., Trittschuh, E. H., Dahl, D., Caulder, E., Neth, B., Montine, T. J., Jung, Y., Maldjian, J., Whitlow, C., and Friedman, S., “Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1325-1334, 2017.
T. A. Lansdell, Xu, H., Galligan, J. J., and Dorrance, A. M., “Effects of Striatal Amyloidosis on the Dopaminergic System and Behavior: A Comparative Study in Male and Female 5XFAD Mice.”, J Alzheimers Dis, vol. 94, no. 4, pp. 1361-1375, 2023.
M. Tsolaki, Karathanasi, E., Lazarou, I., Dovas, K., Verykouki, E., Karacostas, A., Georgiadis, K., Tsolaki, A., Adam, K., Kompatsiaris, I., and Sinakos, Z., “Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial.”, J Alzheimers Dis, vol. 54, no. 1, pp. 129-33, 2016.
J. Jia, Wei, C., Jia, L., Tang, Y., Liang, J., Zhou, A., Li, F., Shi, L., and Doody, R. S., “Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1495-1504, 2017.
J. María García-Alberca, Gris, E., de la Guía, P., Mendoza, S., and de la Rica, M. López, “Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1459-1469, 2023.
J. María García-Alberca, Gris, E., de la Guía, P., Mendoza, S., and de la Rica, M. López, “Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1459-1469, 2023.
H. Shimada, Doi, T., Tsutsumimoto, K., Makino, K., Harada, K., Tomida, K., and Arai, H., “Elevated Risk of Dementia Diagnosis in Older Adults with Low Frequencies and Durations of Social Conversation.”, J Alzheimers Dis, vol. 98, no. 2, pp. 659-669, 2024.
J. Wang, Qiao, F., Shang, S., Li, P., Chen, C., Dang, L., Jiang, Y., Huo, K., Deng, M., Wang, J., and Qu, Q., “Elevation of Plasma Amyloid-β Level is More Significant in Early Stage of Cognitive Impairment: A Population-Based Cross-Sectional Study.”, J Alzheimers Dis, vol. 64, no. 1, pp. 61-69, 2018.
J. Wang, Qiao, F., Shang, S., Li, P., Chen, C., Dang, L., Jiang, Y., Huo, K., Deng, M., Wang, J., and Qu, Q., “Elevation of Plasma Amyloid-β Level is More Significant in Early Stage of Cognitive Impairment: A Population-Based Cross-Sectional Study.”, J Alzheimers Dis, vol. 64, no. 1, pp. 61-69, 2018.
B. Dubois, “The Emergence of a New Conceptual Framework for Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1059-1066, 2018.
H. Hochstetler, Trzepacz, P. T., Wang, S., Yu, P., Case, M., Henley, D. B., Degenhardt, E., Leoutsakos, J. - M., and Lyketsos, C. G., “Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline.”, J Alzheimers Dis, vol. 50, no. 1, pp. 271-82, 2016.

Pages